AgingNCT06638060
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC
An observational study of Aging, run by Medtronic - MITG at 1 site in Canada.
Trial summary
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home . Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aging
- How many people
- 15 participants
- Where
- 1 siteCanada
- Study dates
- 13 Mar 2025to 21 Jun 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.
Who may be able to join
- Inpatients on the Acute care of the Elderly ward.
Who cannot join
- Lack of capacity to consent to the study including moderate-severe dementia or delirium
- Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
- Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
- Patient with known allergic reactions to any part material of the device
- People under 40kg
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
St. Paul'sHospital
Vancouver, British Columbia, V6Z 1Y6
Janet Kow, MD, jkow@providencehealth.bc.ca
Janet Kow, MD
About this study
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .
- Conditions
- Aging
What is being measured
The primary outcome is the main question the study is designed to answer.
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the Usability Questionnaire.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed via an assessment of the data flow: does the correct patient data reach the clinicians at the right time?
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, labs and other collected data.
Measured: From enrollment to the end of follow up at 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start13 Mar 2025
- Primary completion21 Jun 2027 (estimated)
- Study completion21 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AgingStudies of the same condition, open and under way.
- More trials run by Medtronic - MITGThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Medtronic - MITG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06638060
- Sponsor's protocol ID
- H24-00744
- Status last verified
- Oct 2026
- First submitted
- 16 Sep 2024
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC
- ClinicalTrials.gov ID
- NCT06638060
- Acronym / sponsor ID
- H24-00744
- Conditions
- Aging
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 15 participants (estimated)
- Lead sponsor
- Medtronic - MITGIndustry (pharma, biotech, devices)
- Collaborators
- Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
- Study start
- 13 Mar 2025 (actual)
- Primary completion
- 21 Jun 2027 (estimated)
- Study completion
- 21 Jun 2028 (estimated)
- First posted
- 15 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.
Key inclusion criteria (1 listed)
- Inpatients on the Acute care of the Elderly ward.
Key exclusion criteria (5 listed)
- Lack of capacity to consent to the study including moderate-severe dementia or delirium
- Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
- Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
- Patient with known allergic reactions to any part material of the device
- People under 40kg
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the Usability Questionnaire.
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the data flow: does the correct patient data reach the clinicians at the right time?
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, labs and other collected data.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Aging
Enrolling by invitationPhase 2
Tirzepatide and Organ-specific Biological Aging
Longevity, Preventive Medicine
Active, not recruiting
Emotional Well-being and Measures of Healthy Aging
Aging, Aging, Healthy
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Active, not recruiting
Vascular Aging and Lp299v Study in Healthy Adults
Vascular Aging
RecruitingObservational study
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Aging, run by Medtronic - MITG at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elise Huisman (+1 236-308-4876, elise.huisman@medtronic.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Collect patient and clinicians' feedback about the CCPC Platform (time frame: From enrollment to the end of follow up at 10 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.